Thalidomide-O-C8-NH2 hydrochloride is primarily used in research settings for its potential therapeutic applications, particularly in the study of immunomodulatory and anti-inflammatory effects. It is often employed in experimental studies to investigate its role in targeting specific cellular pathways, such as those involved in cancer and autoimmune diseases. Researchers utilize this compound to explore its ability to inhibit angiogenesis, which is crucial in the development of treatments for conditions like multiple myeloma and other malignancies. Additionally, it serves as a valuable tool in the development of novel drug delivery systems, aiming to enhance the efficacy and reduce the side effects of thalidomide-based therapies. Its modified structure allows for improved solubility and bioavailability, making it a promising candidate for further pharmacological studies.